Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Cefepime (4th Gen) Injectable (IV/IM) bulk supplier for pharma manufacturers

Cefepime (4th Gen) Injectable (IV/IM) 1 g, 2 g, 4 g per vial Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV/IM)

Available Strengths: 1 g, 2 g, 4 g per vial

Reference Brands: Maxipime(US & EU)

Category: Antibiotics

Cefepime powder for injection in 1 g, 2 g and 4 g vials, a fourth-generation cephalosporin for serious hospital infections. For hospital pharmacies, importers, distributors and antibiotic tender buyers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cefepime (4th Gen) Injectable (IV/IM)? List it or send an offer →

Product Description:

Cefepime is a fourth-generation cephalosporin. Like other beta-lactams it binds penicillin-binding proteins and stops bacteria building their cell wall. It enters Gram-negative cells quickly and resists many AmpC beta-lactamases, so it covers Pseudomonas aeruginosa and Enterobacterales as well as methicillin-sensitive staphylococci. ESBL producers usually break it down. This page covers sterile powder in vials listed as 1 g, 2 g and 4 g, reconstituted for intravenous infusion or deep intramuscular injection.

Labelled uses include moderate to severe pneumonia, empirical therapy of febrile neutropenia, complicated urinary tract infections, skin infections and, with metronidazole, complicated intra-abdominal infections. WHO places it in the Watch group of its AWaRe classification, so stewardship rules apply. Infusions usually run over about 30 minutes every 8 to 12 hours. Doses must be cut in renal impairment, because accumulation can cause encephalopathy, myoclonus and non-convulsive seizures. It is avoided after serious beta-lactam allergy, and Clostridioides difficile diarrhoea is a recognised risk.

Sourcing notes. Cephalosporins must be made in dedicated or fully segregated beta-lactam facilities, so ask for a GMP certificate covering sterile cephalosporin production. The 1 g and 2 g vials are the standard strengths; confirm that any 4 g presentation is registered in your market. A CTD or ACTD dossier should cover sterility assurance, endotoxins, particulate matter and stability of dry powder and reconstituted solution. Dry vials are stored at room temperature, protected from light. Ask for a CoA per batch, the CoPP and the vial and stopper specification. State strength, vials per carton and any diluent.

Cefepime (4th Gen) Injectable (IV/IM) — third party manufacturing & bulk supply

Cefepime (4th Gen) Injectable (IV/IM) 1 g, 2 g, 4 g per vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefepime (4th Gen) Injectable (IV/IM) is supplied as Injectable (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefepime (4th Gen) Injectable (IV/IM) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefepime (4th Gen) Injectable (IV/IM) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cefepime (4th Gen) Injectable (IV/IM) is listed as Injectable (IV/IM) in 1 g, 2 g, 4 g per vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefepime (4th Gen) Injectable (IV/IM) is referenced against Maxipime(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Ceftazidime Powder for Solution

Strength:
1 g, 2 g, 2.5 g, 3 g, 4 g

Form: Powder for Solution

Reference Brands: Fortaz (US & EU)

View Details
Cefoperazone / Sulbactam IV Solution

Strength:
1 g cefoperazone + 1 g sulbactam

Form: Intravenous (IV)

Reference Brands: -

View Details
Ceftazidime Injectable (IV/IM)

Strength:
1 g, 2 g, 2.5 g, 3 g, 4 g per vial

Form: Injectable (IV/IM)

Reference Brands: Fortaz (US & EU)

View Details
Cefixime Suspension

Strength:
100 mg/5 mL, 200 mg/5 mL

Form: Suspension

Reference Brands: Suprax(US & EU)

View Details
Bedaquiline

Strength:
100 mg

Form: Tablets

Reference Brands: Sirturo (USA/EU)

View Details
Tedizolid Phosphate

Strength:
200 mg

Form: Tablet / Injection

Reference Brands: Sivextro (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us